ESMO 2025

European Society for Medical Oncology (ESMO) Annual Meeting

SOPHiA GENETICS is excited to be part of the European Society For Medical Oncology (ESMO) Annual Meeting.

You will have the chance to chat with our experts at booth #2039 to discuss our solutions for BioPharma and to demo the universal SOPHiA DDM™ Platform and the dedicated Digital Twins module within SOPHiA CarePath®.

Visit us at Booth #2039 and find out how to:

✅ Transform your precision therapy journey with next-generation genomics solutions tailored to your unique requirements

✅ Optimize each stage of drug development with efficient end-to-end Clinical Trial Assay (CTA) and CDx development

✅ Rise above the noise and trust your results with decentralized and best-in-class NGS solutions

✅ Transform oncology data complexity into valuable insights with the power of AI

✅ Streamline your market access strategy by unveiling insights from real-world data

✅ Accelerate global testing adoption and enable sustainable patient access to precision therapies by harnessing the vast global SOPHiA DDM® network

Meet us there!

Book a Meeting

Comments

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Institution(Required)

Job Function(Required)

Area of Interest(Required)

Email(Required)

Phone(Required)

Country(Required)

Select US State

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

CAPTCHA

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services